Ignite Creation Date:
2025-12-26 @ 2:39 PM
Ignite Modification Date:
2025-12-29 @ 11:34 AM
Study NCT ID:
NCT03053206
Status:
UNKNOWN
Last Update Posted:
2017-02-15
First Post:
2017-02-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Prospective, Interventional Study Assessing Response to Cytarabine, Daunorubicin and Etoposide (ADE) for First Relapse of Paediatric Acute Myeloid Leukemia
Sponsor:
All India Institute of Medical Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2019-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2017-02-07
First Submit QC Date:
None
Study First Post Date:
2017-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-10
Last Update Post Date:
2017-02-15
Last Update Post Date Type:
ACTUAL